Clobetasol Propionate Foam recalled over manufacturing violations
- Recall date
- January 10, 2022
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Ingenus Pharmaceuticals Llc recalls Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC 50742-304-01), Rx…
- Recall number
- D-0374-2022
- FDA classification
- Class II
- Brand / firm
- Ingenus Pharmaceuticals Llc
- Sold / distributed
- Nationwide in the USA
Why it was recalled
CGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Clobetasol Propionate Foam, 0.05%, packaged in a) 50 g can (NDC 50742-304-50), and b) 100 g can (NDC 50742-304-01), Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC, Orlando, FL 32839-6408.
Get recall alerts
Free email alert whenever Ingenus Pharmaceuticals Llc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Ingenus Pharmaceuticals Llc